Precision Surgery: Intraoperative Molecular Imaging to Improve Margin Detection

In this installment of the NCI Imaging and Informatics Community Webinar, Stanford Cancer Center Medical Director, Dr. Eben Rosenthal, will present how the use of intraoperative molecular imaging (IMI) can help surgeons identify and sample the area on a tumor most likely to contain a tumor-positive margin (the edge of tissue containing cancer cells).

The high rate of tumor-positive margins in head and neck cancer (HNC) are directly correlated with lower survival rates but have remained a gap in the quality of care for these patients for the last 2 decades. Leveraging imaging analysis technology that accurately identifies these margins during surgery has the potential to double the 5-year survival rate of HNC patients.